Audentes Therapeutics Inc Cmn (BOLD) 15.99 $BOLD
Post# of 273322
Posted On: 09/27/2016 5:01:19 PM
Audentes Therapeutics Inc Cmn (BOLD) 15.99 $BOLD
Audentes Therapeutics to Present at Upcoming Investor Conferences
PR Newswire - Wed Sep 21, 7:00AM CDT
Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, today announced that Matthew R. Patterson, President and Chief Executive Officer, will present at the following upcoming investor conferences:
BOLD: 15.99 (-0.32)
Audentes Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update
PR Newswire - Wed Aug 31, 3:05PM CDT
Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, today reported its financial results for the quarter ended June 30, 2016 and provided an update on the company's recent achievements and upcoming events.
BOLD: 15.99 (-0.32)
The Alliance for Regenerative Medicine Welcomes New Vice Chairman Matthew Patterson, President and CEO, Audentes Therapeutics
Marketwired - Thu Aug 11, 8:00AM CDT
WASHINGTON, DC--(Marketwired - Aug 11, 2016) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, announced today that Matthew Patterson, president and CEO, Audentes Therapeutics, Inc., has been named vice chairman of ARM, effective immediately.
BOLD: 15.99 (-0.32), SGMO: 4.93 (+0.07)
Audentes Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference
PR Newswire - Mon Aug 08, 7:00AM CDT
Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening diseases, today announced that Matthew R. Patterson, President and Chief Executive Officer, will present at the 2016 Wedbush PacGrow Healthcare Conference on Wednesday, August 17, 2016 at 10:20 am ET.
BOLD: 15.99 (-0.32)
Audentes Therapeutics to Present at Upcoming Investor Conferences
PR Newswire - Wed Sep 21, 7:00AM CDT
Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, today announced that Matthew R. Patterson, President and Chief Executive Officer, will present at the following upcoming investor conferences:
BOLD: 15.99 (-0.32)
Audentes Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update
PR Newswire - Wed Aug 31, 3:05PM CDT
Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, today reported its financial results for the quarter ended June 30, 2016 and provided an update on the company's recent achievements and upcoming events.
BOLD: 15.99 (-0.32)
The Alliance for Regenerative Medicine Welcomes New Vice Chairman Matthew Patterson, President and CEO, Audentes Therapeutics
Marketwired - Thu Aug 11, 8:00AM CDT
WASHINGTON, DC--(Marketwired - Aug 11, 2016) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, announced today that Matthew Patterson, president and CEO, Audentes Therapeutics, Inc., has been named vice chairman of ARM, effective immediately.
BOLD: 15.99 (-0.32), SGMO: 4.93 (+0.07)
Audentes Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference
PR Newswire - Mon Aug 08, 7:00AM CDT
Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening diseases, today announced that Matthew R. Patterson, President and Chief Executive Officer, will present at the 2016 Wedbush PacGrow Healthcare Conference on Wednesday, August 17, 2016 at 10:20 am ET.
BOLD: 15.99 (-0.32)
(0)
(0)